He said the FDA issued two separate and distinct letters showing that the Pfizer shot is still under an emergency-use authorization and that the full FDA approval was given to a BioNtech product, 'Comirnaty', that is similar to the Pfizer gene therapy vaccine. This new shot, Comirnaty, has yet to be manufactured and won't be available for several years because several cardio-toxicity studies have yet to be completed. The Pfizer vaccine does not have emergency use authorization for children under the age of 16, according to the letter. Dr. Malone pointed out that the Pfizer vaccine is fully shielded from liability for any damage, but the BioNtech product is not. Dr. Malone said, "Once again mainstream media has lied to you. I'm sorry to say that, I know it's a shock to this viewership, but the product that's licensed is the BioNtech product, which is substantially similar but not necessarily identical, It's called Comirnaty…" After this, the FDA skipped using outside advisory committees and public comments before approval -GEG